BioAtla, Inc.

BCAB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$70-$123-$106-$95
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0-$1
Stock-Based Comp.$9$14$15$25
Change in WC-$11$5$0$7
Other Non-Cash-$1$0$0$0
Operating Cash Flow-$72-$104-$90-$62
Investing Activities
PP&E Inv.$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0-$0-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$9$0$62$71
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0-$1
Financing Cash Flow$10$0$61$70
Forex Effect$0$0$0$0
Net Chg. in Cash-$62-$104-$29$6
Supplemental Information
Beg. Cash$111$216$245$239
End Cash$49$111$216$245
Free Cash Flow-$72-$104-$91-$63